Mysimba 8 mg/90 mg prolonged-release tablets *

• Company:

  Consilient Health Ltd

• Status:

  No Recent Update

• Legal Category:

  Product subject to medical prescription which may not be renewed (A)

• Active Ingredient(s):

  Bupropion Hydrochloride Naltrexone Hydrochloride

  This medicinal product is subject to additional monitoring.

  *Additional information is available within the SPC or upon request to the company